Navigation Links
NuVasive to Present at Barclays Capital Global Healthcare Conference
Date:3/3/2009

SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer and Kevin O'Boyle, Executive Vice President & Chief Financial Officer, are scheduled to present at the Barclays Capital Global Healthcare Conference at Loews Miami Beach Hotel in Miami Beach, Florida on Tuesday, March 10, 2009, at 8:30 a.m. ET.

A live Web cast of the presentation will be available online from the investor relations page of the Company's corporate Web site at www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, www.nuvasive.com, for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(R), as well as a growing offering of biologics, cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines four categories of current product offerings: NeuroVision(R) a proprietary software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; biologics; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption durin
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results
2. NuVasive Announces Web Cast and Conference Call of Fourth Quarter 2008 Results
3. NuVasive to Present at Canaccord Adams Musculoskeletal Conference
4. NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference
5. NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results
6. NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference
7. NuVasive to Present at 20th Annual Piper Jaffray Health Care Conference
8. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
9. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. NuVasive Acquires First Stem Cell Bone Graft Substitute
11. NuVasive Reports First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...a rise in child deaths linked to flu, , ...h officials said Monday that H1N1 swine flu infect...the number of American children dying from the ill...leased Monday by the U.S. Centers for Disease Cont...ctors for influenza-like illness nationally decrea...
(Date:11/30/2009)...wire-USNewswire/ -- SEIU Local 21LA members and Ne...xo will hold a rally Tuesday, Dec. 1, 2009, at noo...s, 3800 Desire Parkway, New Orleans, to protest an...ary policies that target employees who are ill or ...employees who clean schools in the Recovery School...
(Date:11/30/2009)... Jedi Mind, Inc . (Pink ...announce the Company,s first thought-controlled ga...e, "Think-Tac-Toe" is the first of its kind, which...f their mind and is geared towards people of all a...9 and can be purchased directly through the Compan...
(Date:11/30/2009)...ses Tent To Simulate High Altitude, Low O2 Conditi...ire/ -- Distance runners who live at high altitude...r performance during races in areas that are at se...from fatigue, improve their exercise performance b... ,, That is the question being studied among 15...
(Date:11/30/2009)...ov. 30 Tyco Internationa...0 annual general meeting of shareholders will be h...ral European time at the Park Hyatt Zurich Hotel, ...gistered shareholders as of January 11, 2010 (the ...l general meeting. Additionally, individuals who ...
Breaking Medicine News(10 mins):Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4
..., including two fatal hemorrhagic dengue, have bee... Grosso do Sul in January, official// news agency ...genor Alvares described this figure as very high, ... fight the disease, noting that "as soon as we kne...
...erma Center together with engineers from the unive...ith this nifty monitor that// checks a patient's f...ults from the evaluation of the device seem to be ...rs that alternately record skin and ambient temper...
...esign aims to solve the problem of dosage variance...drug treatments for children.// The new Wat...eatures and has been designed to appeal to kids, w... and addresses several concerns associated with tr...
...ouse to help people with dementia. //It uses smart...ng when it thinks there may be a problem. T...f Medical Engineering could mean elderly people wi.... Dementia is a progressive brain dysfuncti...
...usly a difficult question to answer. //There is no... stem cell research that this is a fast growing an...icine. Ideally a properly funded national s...us because that is not an option for them: there a...
...pecies of bacteria dwelling on the human forearm,...hich prompts lead researcher Martin Blaser to conc...an body. Stating that he wanted to explore the...results of his work, which he describes as ‘deep.’...
Other Medicine News:Health News:Space-Age Bandage Monitors Patients With Raynaud's Disease 2Health News:New Inhaler is Child's Play 2Health News:New Inhaler is Child's Play 3Health News:‘Smart House’ Developed to Monitor People With Dement 2Health News:Unknown Species of Bacteria Among a ‘zoo’ of Them on the Human Bo 2
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Cardiac Defibrillators - A Worldwide Ma...linker.com/p0164315/Cardiac-Defibrillators---A-Wor...diovascular disease (CVD) is one of the foremost c...urvivors are prone to arrhythmic disorders, callin...
(Date:11/30/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Europe Ophthalmic Devices Investment Opp... http://www.reportlinker.com/p0166515/Europe-Ophth...d-Forecasts-to-2015.html ,, Europe Ophthalmic ...ecasts to 2015 ,, Summary ,, This report i...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: ...clinical documentation services, is featuring a ne...f North America (RSNA) conference in Chicago. Cal...ages SpeechQ(TM), the company,s real-time interact...ds of radiologists. MedQuist has integrated Speec...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Independence Blue Cross Appoints Lauren OBrien Vice President Chief Accounting Officer 61519 1Independence Blue Cross Appoints Lauren OBrien Vice President Chief Accounting Officer 61519 2Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 1Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 2Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 3Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 4FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 1FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 2FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 3FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 4
...EAL, Aug. 20 Enobia Pharma, an emerging biotech,c...r serious bone,disorders, today announced that the...sphatasia has been dosed. Enobia is investigating ... the treatment of this rare and,often crippling ge...,treatment., Under two separate protocols, ENB-00...
...OLIS, Md., Aug. 20 Do you currently have a study,...given your sites,recruitment tools and a budget fo...s? Perhaps what you need is an extra set of hands ...cements and provide additional,administrative assi...Assist(TM) service," says Ms. Ann Kottcamp,Preside...
Other Medicine Technology:Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 3Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2
...e customized with selectable performance parameter... The COLLEAGUE pumps allow the same IV delivery s...n, eliminating wasteful teardowns and excess costs...quiring complex dose calculations, COLLEAGUE pumps...
...is dedicated to the principles of excellence and c...committed to aiding the clinician in early diagnos...sign of profiles and panels that provide the order...sts assist to resolve the various clinical problem...
Clinical Reference Laboratory (CRL)
Focus Diagnostics
Medicine Products: